Opdivo Qvantig is the first subcutaneously administered PD-1 inhibitor approved by the FDA. It is expected to be available in ...

Here are the top performing articles about obesity published this year on Managed Healthcare Executive. 1. GLP-1 Tiering ...

One of this year's top articles on cost and coverage highlights that the average American can afford a maximum of $97 in ...

Of the top news articles, Vertex Pharmaceuticals' suzetrigine garnered much attention as it's a promising new class of pain ...

Historically, healthcare organizations have considered the contact center to be a cost center, a communications platform for ...

Take a look at the best performing print articles of 2024. This year's top article spotlights the surge of mRNA vaccines ...

Liraglutide injection is now approved for adult and pediatric patients ages 10 and up, proving another option amid the GLP-1 ...

Kamilia Smith, MD, FACOG, NCMP, discusses how societal stigma and cultural misconceptions about menopause, combined with ...

Take a look at the best performing print articles of 2024. This year's top article spotlights the surge of mRNA vaccines ...

Up to half of obstructive sleep apnea patients taking Zepbound had no symptoms after one year of treatment, averaging 25 ...

Anna Podolanczuk, M.D., M.S., discusses how key epidemiological trends in idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF), including changes in incidence and prevalence, ...

Gene therapies are revolutionizing treatment for hemophilia A and sickle cell disease; however, they are saddled with hefty ...